| Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation (NCT04368559) | Mundipharma Research Limited | 2020-05-11 |
| Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry Feet (NCT04265521) | Biocool AB | 2020-03-03 |
| Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients (NCT04157465) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2019-11-07 |
| A Study of Itraconazole in the Management of Superficial Fungal Infections in India (NCT03923010) | Janssen Research & Development, LLC | 2019-08-06 |
| Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis (NCT03667690) | Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2018-10-07 |
| Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization (NCT02888197) | Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2016-08-16 |
| CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension (NCT02734862) | Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2016-07-26 |
| RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections (NCT02733432) | Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2016-06-08 |
| Invasive Mould Infections in Indian ICUs - Descriptive Epidemiology, Management and Outcome (NCT02683642) | Fungal Infection Study Forum | 2016-04-01 |
| Descriptive Epidemiology on Management of Mucormycosis (NCT03429023) | Fungal Infection Study Forum | 2016-04-01 |
| Validation of Pathologic Diagnosis of Invasive Fungal Infection by Molecular Method (NCT02676570) | Seoul St. Mary's Hospital | 2016-02-01 |
| Effect of Inflammation on Pharmacokinetics of Posaconazole (NCT02492802) | University Medical Center Groningen | 2015-08-13 |
| Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis (NCT02244606) | Scynexis, Inc. | 2014-09-01 |
| Prospective Data Bank Creation to Study Vaginal Conditions (NCT01829204) | Texas Tech University Health Sciences Center | 2013-04-01 |
| Assessment of the Fungal Infection Incidence Across Canada for High Risk Participants With Hematological Disease (P07501) (NCT01254318) | Merck Sharp & Dohme LLC | 2013-03-01 |
| Bioequivalence Study for Terbinafine 250 mg (NCT01772212) | GlaxoSmithKline | 2011-02-24 |
| Effect of Weight and/or Obesity on Anidulafungin Drug Concentrations (NCT01307930) | Texas Tech University Health Sciences Center | 2011-01-01 |
| Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients (NCT00841971) | University of Pittsburgh | 2010-02-01 |
| Pre-hospital Risk Factors for Invasive Fungal Infection (NCT01315925) | Catholic University of the Sacred Heart | 2010-01-01 |
| Liver Transplant European Study Into the Prevention of Fungal Infection (NCT01058174) | Astellas Pharma Inc | 2009-12-15 |
| Antifugal Effect of Recombinant Human Granulocyte-macrophage Stimulating Factor (rhGM-CSF) in Patients Post Allo-HSCT (NCT01232504) | Xiamen Amoytop Biotech Co., Ltd. | 2009-09-01 |
| Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma (NCT00896493) | Stanford University | 2009-05-01 |
| Therapeutic Drug Monitoring of Voriconazole (NCT00890708) | Seoul National University Hospital | 2008-11-01 |
| Evaluation of Treatment and Prophylaxis of Invasive Fungal Infections in Immuncompromised Patients in Austria (Study P05532)(WITHDRAWN) (NCT00704951) | Merck Sharp & Dohme LLC | 2008-07-01 |
| Therapeutic Drug Monitoring (TDM) of Voriconazole and Correlation With CYP2C19 Genotype in Korean Populations (NCT00673348) | The Catholic University of Korea | 2008-05-01 |
| A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection (NCT00784368) | Janssen Pharmaceutical K.K. | 2008-01-01 |
| A Study to Examine the Efficacy and Safety of Posaconazole When Introduced Early in the Treatment of Refractory Fungal Infections (P05090 AM2) (NCT00550732) | Merck Sharp & Dohme LLC | 2007-12-01 |
| Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections (NCT00413218) | Astellas Pharma Inc | 2007-03-08 |
| Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation (NCT00336531) | Samsung Medical Center | 2006-04-01 |
| Post-marketing Surveillance Study of Invasive Mycosis With Posaconazole (Study P04641) (NCT00726609) | Merck Sharp & Dohme LLC | 2006-01-01 |
| Voriconazole as Prophylaxis for Liver Transplant Recipients (NCT00177788) | University of Pittsburgh | 2005-09-01 |
| Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095) (NCT00034632) | Merck Sharp & Dohme LLC | 2001-04-01 |
| Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections (NCT00015665) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-04-01 |
| PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893) (NCT00034671) | Merck Sharp & Dohme LLC | 2001-01-01 |
| Voriconazole to Prevent Systemic Fungal Infections in Children (NCT00005912) | National Cancer Institute (NCI) | 2000-06-01 |
| Voriconazole to Treat Fungal Infections (NCT00001940) | National Cancer Institute (NCI) | 1999-12-01 |
| Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients (NCT00001937) | National Cancer Institute (NCI) | 1999-11-01 |
| New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia (NCT00342589) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-09-28 |
| An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections (NCT00001810) | National Cancer Institute (NCI) | 1999-04-01 |
| Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients With Graft vs. Host Disease (NCT00034645) | Merck Sharp & Dohme LLC | 1999-01-01 |
| Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041) (NCT00034658) | Merck Sharp & Dohme LLC | 1998-12-01 |
| Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia (NCT00001790) | National Cancer Institute (NCI) | 1998-10-01 |
| An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections (NCT00001757) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-11-01 |
| Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Disease (NCT00001280) | National Institute of Allergy and Infectious Diseases (NIAID) | 1991-01-01 |
| Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy (NCT00002038) | Pfizer | |
| A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients (NCT00002122) | Pfizer | |
| A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections (NCT00002277) | Pfizer | |
| Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081) (NCT00000676) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113) (NCT00686621) | Merck Sharp & Dohme LLC | |
| A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common (NCT00002325) | Pfizer | |